Besifloxacin Hydrochloride

盐酸贝西沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameBesifloxacin Hydrochloride
Drug Alias NameBesifloxacinumBesifloxacinoBesivanceSS-734BOL-303224-A +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsCataractConjunctivitis, Bacterial
Global Approved IndicationsConjunctivitis, Bacterial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2009/05/28
Country/TerritoryUnited StatesMexicoMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBausch & Lomb
China Registration ClassN/A

Develop Information

Active CompaniesBausch And Lomb IncBausch & Lomb Co Ltd
Inactive CompaniesBausch & Lomb IncorporatedInstituto De Oftalmología F.A.P. Conde De Valenciana, I.A.P
Active IndicationsConjunctivitis, Bacterial
Inactive IndicationsCataract

Other Information

ATC CodeS01AE08
Related LinksWikipediaDrugBankKEGG